: The end organ sequelae of atherosclerosis and hypertension represent the largest public health problems in industrialized populations. The importance of arachidonic acid (AA) and its metabolites in modulating vascular tone, cell growth, migration, proliferation and gene expression is well known. The rate determining step in the production of eicosanoids is the release of AA by intracellular phospholipases A2 (PLA2). Accordingly, a detailed understanding of the types and modes of regulation of vascular cell intracellular PLA2S are necessary to gain insight into the critical signaling mechanisms, which mediate atherosclerotic, and hypertensive disease states. We have identified the major vascular intracellular phospholipases as iPLA2B and 1PLA2Gamma The structure of iPLA2B is remarkable for: 1) the presence of ankyrin-like repeat domains in its N-terminus which likely modulate protein-protein interactions facilitating its intracellular sorting; and 2) a calmodulin binding domain in its C-terminus which regulates its activity. Accordingly, in Specific Aim 1 we will examine the functional role of the N-terminal ankyrin-like repeat domains in iPLA2B by identifying its protein binding partners. Next, we will explore the role of phosphorylation of the calmodulin binding domain to elucidate the role of protein kinases in regulating iPLA2B activity. Finally, the role of proteolytic activation of iPLA2B activity by caspase-3 and calpain-mediated cleavage will be examined.
In Specific Aim 2, we will generate smooth muscle cell (SMC) specific overexpressors and mice null for IPLA2B and 1PLA2gamma in a SMC specific manner to determine the role of iPLA2s in vascular SMC tone, proliferation and migration.
In Specific Aim 3, we will explore the newly identified role of AA as a modulator of endothelial cell (EC) nitric oxide production and the roles of Akt mediated activation of eNOS and iPLA2B in NO production. Finally, by exploiting chiral mechanism-based inhibitors of iPLA2B and iPLA27 we have developed, we will examine the role of intracellular phospholipases in EC responses to cyclic mechanical force. Alterations in the release of AA, generation of eicosanoid metabolites, lipid composition and cytoskeletal organization during changes in shear stress and mechanical stretch will be examined. Collectively, these studies represent a targeted, multidisciplinary approach to elucidate the roles of intracellular phospholipases in the vascular biology of the hypertensive and atherosclerotic disease states.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL041250-11
Application #
6624165
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Lin, Michael
Project Start
1988-07-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
11
Fiscal Year
2003
Total Cost
$344,250
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Murata, Takahiro; Dietrich, Hans H; Horiuchi, Tetsuyoshi et al. (2016) Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles. Neurosci Res 107:57-62
Li, Anlong; Knutsen, Russell H; Zhang, Haixia et al. (2013) Hypotension due to Kir6.1 gain-of-function in vascular smooth muscle. J Am Heart Assoc 2:e000365
Murata, Takahiro; Dietrich, Hans H; Xiang, Chuanxi et al. (2013) G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats. Stroke 44:779-85
Liu, Xinping; Moon, Sung Ho; Mancuso, David J et al. (2013) Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation. Anal Biochem 442:40-50
Jenkins, Christopher M; Yang, Jingyue; Gross, Richard W (2013) Mechanism-based inhibition of iPLA2? demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition. Biochemistry 52:4250-63
Moon, Sung Ho; Jenkins, Christopher M; Liu, Xinping et al. (2012) Activation of mitochondrial calcium-independent phospholipase A2? (iPLA2?) by divalent cations mediating arachidonate release and production of downstream eicosanoids. J Biol Chem 287:14880-95
Osei-Owusu, Patrick; Sabharwal, Rasna; Kaltenbronn, Kevin M et al. (2012) Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling. J Biol Chem 287:12541-9
Moon, Sung Ho; Jenkins, Christopher M; Kiebish, Michael A et al. (2012) Genetic ablation of calcium-independent phospholipase A(2)? (iPLA(2)?) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release. J Biol Chem 287:29837-50
Dietrich, Hans H (2012) Cell-to-cell communication and vascular dementia. Microcirculation 19:461-7
Sharma, Janhavi; Turk, John; Mancuso, David J et al. (2011) Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells. Am J Physiol Cell Physiol 300:C872-9

Showing the most recent 10 out of 52 publications